Skip to content

Ashfield U.S. is pleased to announce the appointment of Amy Van Sant as President of their new Medical Affairs business unit and Lee Ann Chaiken as Senior Vice President of Ashfield’s Pharmacovigilance business.

The new Medical Affairs business unit will combine Ashfield’s existing Medical Information, Pharmacovigilance and Medical Science Liaison services. The unit is being established as part of Ashfield’s five-year growth plan to provide its clients leading services across the entire healthcare value chain by investing in people, technology and infrastructure. Amy’s role will be focused on raising awareness of Ashfield’s Medical Affairs capabilities and executing the flexible and scalable programs clients require. She will be located in the Fort Washington, PA corporate headquarters of Ashfield U.S.


Amy assumes her position at Ashfield U.S. having most recently served as Director, Regulatory Advertising & Promotion for the Pharmaceutical Sector within the Johnson & Johnson Health Care Compliance & Privacy Organisation. Amy holds a Doctorate of Pharmacy from the University of the Sciences, Philadelphia, and an MBA in Pharmaceutical Management from Drexel University.




Lee Ann Chaiken has been appointed Senior Vice President of Ashfield’s Pharmacovigilance unit headquartered in Durham, NC, reporting directly to Amy Van Sant. Ashfield’s Pharmacovigilance business is recognised as delivering world-class safety and risk management services to meet the ever-changing complex regulations and demands for product safety within the pharmaceutical, biotech, consumer health/over-the-counter, and medical device categories.


Commenting on the appointments and launch of the Medical Affairs business unit, Greg Flynn, President Ashfield U.S. said: “I am delighted to welcome Amy and Lee to Ashfield.  Investment in talent is key to our business, and we are delighted to have these leaders with deep subject matter expertise join us. Their appointments underscore our commitment to providing best-in-class medical affairs solutions and providing our biopharmaceutical clients with seamless, end-to-end commercialisation services. We believe having one business unit, under the capable direction of Amy Van Sant, will offer our clients a much stronger and effective solution to their medical affairs issues.“

Amy, who previously worked for Ashfield in the position of Director, Medical Information stated, “I am excited to be joining Ashfield again at such a pivotal time in its growth story in the US. Our mission is to become the industry leader for healthcare companies outsourcing their Medical Affairs programs, including Medical Information, Medical Science Liaison and Pharmacovigilance. Our focus will be on demonstrating the value our teams create for clients and providing high quality, innovative solutions.”

Lee’s most recent experience was as Senior Director, IT implementation Services, IQVIA where she led the operational implementation of SaaS safety services across the client base.  On her appointment, Lee said:  “It is a privilege to be a part of the Ashfield PV organisation.  We are passionate about patient safety and the partnerships we form with healthcare companies.  To be a part of an organisation that holds quality, expertise and ingenuity as core values and a commitment to ensuring industry leading Medical Affairs services is invigorating.”